# Analgesic Agents - Opioids

[Criteria Document](https://mygainwell-my.sharepoint.com/:w:/g/personal/kaelyn_dobbins_gainwelltechnologies_com/EavixVJTp-lLrPNk5wnba-EBh0tdXFUKnwnI_Ps6rZodQQ?e=UUzJaQ){:target="_blank" rel="noopener}

<table>
<thead>
<tr class="header">
<th>Criteria 1   </th>
<th><p>NP Agents – Short Acting Agents- Acetaminophen/Caffeine/Dihydrocodeine, Benzhydrocodone/Acetaminophen,</p>
<p>Butalbital/Acetaminophen/Caffeine/Codeine 50/300/40/30mg, Dsuvia, Hydrocodone/Acetaminophen 5-300, Hydrocodone/Acetaminophen 7.5-300, Hydrocodone/Acetaminophen 10-300mg, Hydrocodone/Ibuprofen, Levorphanol, Meperidine, Methadone, Oxycodone/Ibuprofen, Oxymorphone IR, Pentazocine/Naloxone, Seglentis, Tramadol Sol</p></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Criteria 2</td>
<td>NP Agents – Long Acting/Extended-Release Formulations-Belbuca, Buprenorphine TD Patch Weekly, Fentanyl, Hydrocodone Bitartrate ER 12HR Cap, Hydrocodone Bitartrate ER 24HR Tab, Hydromorphone ER, Morphine ER 24HR Cap, Oxycodone ER, Oxymorphone ER, Tramadol ER, Xtampza ER QL</td>
</tr>
<tr class="even">
<td>Criteria 3</td>
<td>Long Acting Preferred Agents- Butrans (BvG), Morphine ER Tab, Nucynta ER</td>
</tr>
<tr class="odd">
<td>Criteria 4</td>
<td>NP Transmucosal Fentanyl Products</td>
</tr>
<tr class="even">
<td>Criteria 5</td>
<td>Preferred Agents – Short Acting Agents- Acetaminophen/Codeine, Butalbital/Acetaminophen/Caffeine/Codeine, Butalbital/Aspirin/Caffeine/Codeine, Butorphanol, Codeine, Hydrocodone/Acetaminophen, Hydromorphone IR, Morphine IR Tab, Morphine IR Sol, Nucynta IR, Oxycodone Cap, Oxycodone Sol, Oxycodone Tab, Oxycodone/Acetaminophen, Tramadol, Tramadol/Acetaminophen</td>
</tr>
</tbody>
</table>

## Non-Preferred Products - Short Acting

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: Opioids</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred Products- Short Acting</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>ACETAMINOPHEN/CAFFEINE/DIHYDROCODEINE</td>
<td>073169</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BENZHYDROCODONE/ACETAMINOPHEN</td>
<td>078222</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BENZHYDROCODONE/ACETAMINOPHEN</td>
<td>079488</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BENZHYDROCODONE/ACETAMINOPHEN</td>
<td>079489</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUTALBITAL/ACETAMINOPHEN/CAFFEINE/CODEINE 50/300/40/30 mg</td>
<td>071253</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DSUVIA</td>
<td>079437</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN 5-300, 7.5-300 and 10-300 mg</td>
<td>057726</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN 5-300, 7.5-300 and 10-300 mg</td>
<td>060338</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN 5-300, 7.5-300 and 10-300 mg</td>
<td>060533</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/IBUPROFEN</td>
<td>034068</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/IBUPROFEN</td>
<td>054674</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/IBUPROFEN</td>
<td>063650</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>LEVORPHANOL</td>
<td>004228</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>LEVORPHANOL</td>
<td>079449</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>004049</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>004051</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>004053</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>059787</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>059790</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>059792</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>059793</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>059794</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>059797</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>059804</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>078735</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>078736</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>079737</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>METHADONE</td>
<td>004235</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>METHADONE</td>
<td>004237</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>METHADONE</td>
<td>004238</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>METHADONE</td>
<td>004239</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>METHADONE</td>
<td>004240</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>METHADONE</td>
<td>004242</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>METHADONE</td>
<td>023767</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>METHADONE</td>
<td>082101</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE/IBUPROFEN</td>
<td>058402</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYMORPHONE IR</td>
<td>061086</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYMORPHONE IR</td>
<td>061087</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>PENTAZOCINE/NALOXONE</td>
<td>004292</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SEGLENTIS</td>
<td>082830</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL SOL</td>
<td>081474</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0009</td>
<td></td>
<td>Select and Free Text</td>
<td>Is the patient new to (initial request) or continuing therapy with the requested product (re-authorization request)?</td>
<td>Initial request for product </td>
<td>0010</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0010</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y</td>
<td>0011</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0011</td>
<td></td>
<td>Select</td>
<td><p>Does this request exceed 30 MED AND/OR exceed a 7 days supply (or 5 days supply if &lt;18 years old)?</p>
<p>Patients with initial prescriptions for opioid therapy, defined as no rx opioid claims in the last 90 days, will be limited to 30 MED per day and a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription.</p></td>
<td>Y</td>
<td>0012</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0013</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0012</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation to support the need for exceeding 30 MED per day and/or a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>0013</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0013</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">7 days</span> of at least <span class="underline">two unrelated</span> preferred drugs of the same duration of action (SHORT-ACTING)?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0014</td>
</tr>
<tr class="odd">
<td>6</td>
<td>0014</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>7 </td>
<td>0015</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>0016</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0017</td>
</tr>
<tr class="odd">
<td>8</td>
<td>0016</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>0017</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>9</td>
<td>0017</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient meet one of the following exemptions?</p>
<p>1) Diagnosis of active cancer treatment, palliative care, end-of-life/hospice care, sickle cell, severe burn, traumatic crushing of tissue, amputation, major orthopedic surgery </p>
<p>2) Prescriber attestation that patient is not opioid naïve (i.e., new to Medicaid or was on higher dose in hospital)</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0018</td>
</tr>
<tr class="odd">
<td>10</td>
<td>0018</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Diagnosis code which must be for somatic type pain</p>
<p>2) Prescriber attestation that the benefits and risks of opioid therapy has been discussed with patient</p></td>
<td>Y</td>
<td>0019</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>11</td>
<td>0019</td>
<td></td>
<td>Select</td>
<td>Does the provider attest that OARRS has been reviewed before initially prescribing or personally furnishing any controlled substance?</td>
<td>Y </td>
<td>0020</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>12</td>
<td>0020</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of the patient’s indication, previous utilization, and requested length of therapy?</td>
<td>Y</td>
<td>0021</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>13</td>
<td>0021</td>
<td></td>
<td>Select</td>
<td>Initial short-acting requests can be authorized up to 90 days. Does this request meet this requirement?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>14</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is the request for a dose escalation?</td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>15</td>
<td>1002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>Prescriber attestation that dose escalation is likely to result in improved function or pain control.</p></td>
<td>Y </td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>16</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td>Is the request for a cumulative daily dose greater than 80 MED?</td>
<td>Y </td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>17</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the medication being prescribed by or in consultation with a pain specialist, specialist in the area of the body affected by pain, or anesthesiologist?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y </td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>18</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Current treatment plan</p>
<p>2) Demonstrated adherence to treatment plan through progress notes, including pain and function scores, random urine screenings results reviewed, concerns addressed, and no serious adverse outcomes observed</p></td>
<td>Y</td>
<td>1006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>19</td>
<td>1006</td>
<td></td>
<td>Select</td>
<td>Subsequent short-acting and dose escalation requests can be authorized up to 180 days. Does this request meet this requirement?</td>
<td>Y</td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>20</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication, dose, and duration being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="even">
<td>21</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: For the course of therapy, up to 180 days.
Initial short-acting and long-acting requests may only be authorized for
up to 90 days.

|||
| ------------------ | --------- |
| **Last Approved ** | 9/21/2023 |
| **Other**          |           |

## Non-Preferred Products - Long Acting

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: Opioids</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred Products- Long Acting</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>BELBUCA</td>
<td>075050</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BELBUCA</td>
<td>075051</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BELBUCA</td>
<td>075052</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BELBUCA</td>
<td>075053</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BELBUCA</td>
<td>075054</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BELBUCA</td>
<td>075055</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BELBUCA</td>
<td>075056</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUPRENORPHINE TD PATCH WEEKLY</td>
<td>059589</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUPRENORPHINE TD PATCH WEEKLY</td>
<td>059590</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUPRENORPHINE TD PATCH WEEKLY</td>
<td>059591</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUPRENORPHINE TD PATCH WEEKLY</td>
<td>071432</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUPRENORPHINE TD PATCH WEEKLY</td>
<td>072673</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL 25 MCG/HR PATCH</td>
<td>015880</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL 50 MCG/HR PATCH</td>
<td>015881</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL 75 MCG/HR PATCH</td>
<td>015882</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL 100 MCG/HR PATCH</td>
<td>015883</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL 12 MCG/HR PATCH</td>
<td>059102</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL 62.5 MCG/HR PATCH</td>
<td>073524</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL 87.5 MCG/HR PATCH</td>
<td>073525</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL 37.5 MCG/HR PATCH</td>
<td>073532</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073621</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073622</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073623</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073624</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073625</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073626</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073176</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073177</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073179</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073180</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073181</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073182</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073183</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROMORPHONE ER</td>
<td>066200</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROMORPHONE ER</td>
<td>069860</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROMORPHONE ER</td>
<td>069889</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROMORPHONE ER</td>
<td>069890</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>050220</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>050221</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>050222</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>064739</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>064740</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>050219</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>060355</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>060356</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>060357</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>060358</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>061722</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>061748</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>061749</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>062358</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE ER</td>
<td>072862</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE ER</td>
<td>072863</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE ER</td>
<td>072864</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE ER</td>
<td>072865</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE ER</td>
<td>072866</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE ER</td>
<td>072867</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE ER</td>
<td>072868</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYMORPHONE ER</td>
<td>061091</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYMORPHONE ER</td>
<td>061092</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYMORPHONE ER</td>
<td>061093</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYMORPHONE ER</td>
<td>061094</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYMORPHONE ER</td>
<td>063782</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYMORPHONE ER</td>
<td>063783</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYMORPHONE ER</td>
<td>063784</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL ER</td>
<td>043536</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL ER</td>
<td>043537</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL ER</td>
<td>060274</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL ER</td>
<td>063422</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL ER</td>
<td>063423</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL ER</td>
<td>063424</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL ER</td>
<td>067760</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL ER</td>
<td>067761</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL ER</td>
<td>067762</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>XTAMPZA ER</td>
<td>076031</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>XTAMPZA ER</td>
<td>076032</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>XTAMPZA ER</td>
<td>076033</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>XTAMPZA ER</td>
<td>076034</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>XTAMPZA ER</td>
<td>076035</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0001</td>
<td></td>
<td>Select and Free Text</td>
<td>Is the patient new to (initial request) or continuing therapy with the requested product (re-authorization request)?</td>
<td>Initial request for product </td>
<td>0002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)</td>
<td>1001</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0002</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y</td>
<td>0003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0003</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following products:</p>
<p>Buprenorphine TD Patch Weekly (generic Butrans), Morphine ER 24HR Cap (generic Kadian)</p></td>
<td>Y</td>
<td>0004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0009</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0004</td>
<td></td>
<td>Select</td>
<td>What product is being requested?</td>
<td>Buprenorphine TD Patch Weekly (generic Butrans)</td>
<td>0005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Morphine ER 24HR Cap (generic Kadian)</td>
<td>0007</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>0009</td>
</tr>
<tr class="even">
<td>5</td>
<td>0005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the brand medication been attempted and failed or is the brand medication contraindicated?  </p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>0006</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>6</td>
<td>0006</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation for doses greater than 5mcg/hour an inadequate clinical response with at least one opioid formulation taken for at least 60 of the last 90 days?</td>
<td>Y</td>
<td>0009</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>7</td>
<td>0007</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is this request being used for cancer pain, palliative care, or end-of-life/hospice care?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>0009</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0008</td>
</tr>
<tr class="even">
<td>8</td>
<td>0008</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of an inadequate clinical response of at least <span class="underline">one</span> opioid formulation taken for at least 60 of the last 90 days?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>0009</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>9</td>
<td>0009</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">7 days</span> of at least <span class="underline">two unrelated</span> preferred drugs of the same duration of action (LONG-ACTING)?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>0011</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0010</td>
</tr>
<tr class="even">
<td>10</td>
<td>0010</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y</td>
<td>0011</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="even">
<td>11</td>
<td>0011</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>0012</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0013</td>
</tr>
<tr class="even">
<td>12</td>
<td>0012</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>0013</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>13</td>
<td>0013</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient meet the following exemption?</p>
<p>Patient is receiving long-acting opioids for cancer pain, palliative care, or end-of-life hospice care</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0014</td>
</tr>
<tr class="even">
<td>14</td>
<td>0014</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<ol type="1">
<li><p>Request is a daily dose equivalent of less than or equal to 80 MED</p></li>
<li><p>Inadequate clinical response to both non-opioid pharmacologic and non-pharmacologic treatments</p></li>
<li><p>Current use of opioids for greater than or equal to 60 of the last 90 days</p></li>
<li><p>Treatment plan including risk assessment, substance abuse history, concurrent therapies, and requirements for random urine screenings (baseline urine drug tests must be submitted)</p></li>
<li><p>Pain and function scores at each visit</p></li>
<li><p>Opioid contract required to be in place and submitted with PA form</p></li>
</ol></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>15</td>
<td>0015</td>
<td></td>
<td>Select</td>
<td>Does the provider attest that OARRS has been reviewed before initially prescribing or personally furnishing any controlled substance?</td>
<td>Y</td>
<td>0016</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>16</td>
<td>0016</td>
<td></td>
<td>Select</td>
<td>Initial long-acting requests can be authorized up to 90 days. Does this request meet this requirement?</td>
<td>Y </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>17</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is the request for a dose escalation?</td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="even">
<td>18</td>
<td>1002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>Prescriber attestation that dose escalation is likely to result in improved function or pain control.</p></td>
<td>Y </td>
<td>1003</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>19</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td>Is the request for a cumulative daily dose greater than 80 MED?</td>
<td>Y </td>
<td>1004</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="even">
<td>20</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the medication being prescribed by or in consultation with a pain specialist, specialist in the area of the body affected by pain, or anesthesiologist?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y </td>
<td>1005</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>21</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Current treatment plan</p>
<p>2) Demonstrated adherence to treatment plan through progress notes, including pain and function scores, random urine screenings results reviewed, concerns addressed, and no serious adverse outcomes observed</p></td>
<td>Y</td>
<td>1006</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>22</td>
<td>1006</td>
<td></td>
<td>Select</td>
<td>Subsequent long-acting and dose escalation requests can be authorized up to 180 days. Does this request meet this requirement?</td>
<td>Y </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>23</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication, dose, and duration being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="odd">
<td>24</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: For the course of therapy, up to 180 days.
Initial short-acting and long-acting requests may only be authorized for
up to 90 days.

|||
| ------------------ | --------- |
| **Last Approved ** | 9/21/2023 |
| **Other**          |           |

## Butrans, Morphine Sulfate ER Tab, Nucynta

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: Opioids</th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Butrans, Morphine Sulfate ER Tab, Nucynta</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>BUTRANS</td>
<td>059589</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>BUTRANS</td>
<td>059590</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>BUTRANS</td>
<td>059591</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>BUTRANS</td>
<td>071432</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>BUTRANS</td>
<td>072673</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER TAB</td>
<td>004096</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER TAB</td>
<td>004097</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER TAB</td>
<td>011886</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER TAB</td>
<td>011887</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER TAB</td>
<td>016522</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>NUCYNTA ER</td>
<td>067266</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>NUCYNTA ER</td>
<td>067267</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>NUCYNTA ER</td>
<td>067268</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>NUCYNTA ER</td>
<td>067270</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>NUCYNTA ER</td>
<td>067271</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><strong>Sequence Number </strong></td>
<td><strong>Question ID </strong></td>
<td><strong>Default Next Question ID </strong></td>
<td><strong>Question Type </strong></td>
<td><strong>Question Text </strong></td>
<td><strong>Choice Text </strong></td>
<td><strong>Next Question ID </strong></td>
</tr>
<tr class="even">
<td>1</td>
<td>0001</td>
<td></td>
<td>Select and Free Text</td>
<td>Is the patient new to (initial request) or continuing therapy with the requested product (re-authorization request)?</td>
<td>Initial request for product </td>
<td>0002</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1001</td>
</tr>
<tr class="even">
<td>2</td>
<td>0002</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling? </td>
<td>Y</td>
<td>0003</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>3</td>
<td>0003</td>
<td></td>
<td>Select</td>
<td>What product is being requested?</td>
<td>Butrans</td>
<td>0004</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Morphine Sulfate ER Tab (generic MS Contin)</td>
<td>0005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Nucynta ER</td>
<td>0005</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>0007</td>
</tr>
<tr class="even">
<td>4</td>
<td>0004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation for doses greater than 5mcg/hour an inadequate clinical response with at least one opioid formulation taken for at least 60 of the last 90 days?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>5</td>
<td>0005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is this request being used for cancer pain, palliative care, or end-of-life/hospice care?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0006</td>
</tr>
<tr class="even">
<td>6</td>
<td>0006</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of an inadequate clinical response of at least <span class="underline">one</span> opioid formulation taken for at least 60 of the last 90 days?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>0007</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>7</td>
<td>0007</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient meet the following exemption?</p>
<p>Patient is receiving long-acting opioids for cancer pain, palliative care, or end-of-life/hospice care.</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0008</td>
</tr>
<tr class="even">
<td>8</td>
<td>0008</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Request is a daily dose equivalent of less than or equal to 80 MED</p>
<p>2) Inadequate clinical response to both non-opioid pharmacologic and non-pharmacologic treatments</p>
<p>3) Current use of opioids for greater than or equal to 60 of the last 90 days</p>
<p>4) Treatment plan including risk assessment, substance abuse history, concurrent therapies, and requirements for random urine screenings (baseline urine drug tests must be submitted)</p>
<p>5) Pain and function scores at each visit</p>
<p>6) Opioid contract required to be in place and submitted with PA form</p></td>
<td>Y</td>
<td>0009</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>9</td>
<td>0009</td>
<td></td>
<td>Select</td>
<td>Does the provider attest that OARRS has been reviewed before initially prescribing or personally furnishing any controlled substance?</td>
<td>Y</td>
<td>0010</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>10</td>
<td>0010</td>
<td></td>
<td>Select</td>
<td>Initial long-acting requests can be authorized up to 90 days. Does this request meet this requirement?</td>
<td>Y </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>11</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is the request for a dose escalation?</td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="even">
<td>12</td>
<td>1002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>Prescriber attestation that dose escalation is likely to result in improved function or pain control.</p></td>
<td>Y </td>
<td>1003</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>13</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td>Is the request for a cumulative daily dose greater than 80 MED?</td>
<td>Y </td>
<td>1004</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="even">
<td>14</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the medication being prescribed by or in consultation with a pain specialist, specialist in the area of the body affected by pain, or anesthesiologist?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y </td>
<td>1005</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>15</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Current treatment plan</p>
<p>2) Demonstrated adherence to treatment plan through progress notes, including pain and function scores, random urine screenings results reviewed, concerns addressed, and no serious adverse outcomes observed</p></td>
<td>Y</td>
<td>1006</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>16</td>
<td>1006</td>
<td></td>
<td>Select</td>
<td>Subsequent long-acting and dose escalation requests can be authorized up to 180 days. Does this request meet this requirement?</td>
<td>Y </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>17</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication, dose, and duration being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: For the course of therapy, up to 180 days.
Initial short-acting and long-acting requests may only be authorized for
up to 90 days.

|||
| ------------------ | --------- |
| **Last Approved ** | 9/21/2023 |
| **Other**          |           |

## Transmucosal Fentanyl Products

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: Opioids</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Transmucosal Fentanyl Products</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CITRATE OTFC 200 MCG</td>
<td>022358</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL CITRATE OTFC 400 MCG</td>
<td>022360</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CITRATE OTFC 600 MCG</td>
<td>041339</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL CITRATE OTFC 800 MCG</td>
<td>041340</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CIT OTFC 1,200 MCG</td>
<td>041341</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL CIT OTFC 1,600 MCG</td>
<td>041342</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CIT 100 MCG BUCCAL TB</td>
<td>061492</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL CIT 200 MCG BUCCAL TB</td>
<td>061493</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CIT 400 MCG BUCCAL TB</td>
<td>061495</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL CIT 600 MCG BUCCAL TB</td>
<td>061496</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CIT 800 MCG BUCCAL TB</td>
<td>061497</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SUBSYS 100 MCG SPRAY</td>
<td>068412</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>SUBSYS 400 MCG SPRAY</td>
<td>068413</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SUBSYS 200 MCG SPRAY</td>
<td>068414</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>SUBSYS 600 MCG SPRAY</td>
<td>068415</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SUBSYS 800 MCG SPRAY</td>
<td>068416</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>SUBSYS 1200 MCG SPRAY</td>
<td>068756</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SUBSYS 1600 MCG SPRAY</td>
<td>068757</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0009</td>
<td></td>
<td>Select and Free Text</td>
<td>Is the patient new to (initial request) or continuing therapy with the requested product (re-authorization request)?</td>
<td>Initial request for product </td>
<td>0010</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0010</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y</td>
<td>0011</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0011</td>
<td></td>
<td>Select</td>
<td><p>Does this request exceed 30 MED AND/OR exceed a 7 days (or 5 days supply if &lt;18 years old) supply?</p>
<p>Patients with initial prescriptions for opioid therapy, defined as no rx opioid claims in the last 90 days, will be limited to 30 MED per day and a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription.</p></td>
<td>Y</td>
<td>0012</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0013</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0012</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation to support the need for exceeding 30 MED per day and/or a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>0013</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0013</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">7 days</span> of at least <span class="underline">two unrelated</span> preferred drugs of the same duration of action (SHORT-ACTING)?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0014</td>
</tr>
<tr class="odd">
<td>6</td>
<td>0014</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>7 </td>
<td>0015</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>0016</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0017</td>
</tr>
<tr class="odd">
<td>8</td>
<td>0016</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>0017</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>9</td>
<td>0017</td>
<td></td>
<td>Select</td>
<td>Is the medication being prescribed by an oncologist, pain specialist, or hospice/palliative prescriber?</td>
<td>Y</td>
<td>0018</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>10</td>
<td>0018</td>
<td></td>
<td>Select</td>
<td><p>Is the patient concurrently taking a long-acting opioid at a therapeutic dose of any of the following for at least <span class="underline">7 days</span> without adequate pain relief:</p>
<ol type="1">
<li><p>Greater than or equal to 60 mg oral morphine/day</p></li>
<li><p>Greater than or equal to 8 mg oral hydromorphone/day</p></li>
<li><p>Greater than or equal to 25 mcg/hr transdermal fentanyl</p></li>
<li><p>Greater than or equal to 25 mg oral oxymorphone/day</p></li>
<li><p>Greater than or equal to 30 mg oral oxycodone/day</p></li>
<li><p>Equianalgesic dose of another opioid</p></li>
</ol></td>
<td>Y</td>
<td>0019</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>11</td>
<td>0019</td>
<td></td>
<td>Select</td>
<td>Ohio Medicaid covers up to 4 doses per day for Transmucosal Fentanyl. Does this request meet this requirement?</td>
<td>Y</td>
<td>0020</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1237</td>
</tr>
<tr class="odd">
<td>12</td>
<td>0020</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient meet one of the following exemptions?</p>
<ol type="1">
<li><p>Diagnosis of active cancer treatment, palliative care, end-of-life/hospice care, sickle cell, severe burn, traumatic crushing of tissue, amputation, major orthopedic surgery </p></li>
<li><p>Prescriber attestation that patient is not opioid naïve (i.e., new to Medicaid or was on higher dose in hospital)</p></li>
</ol>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0021</td>
</tr>
<tr class="odd">
<td>13</td>
<td>0021</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Diagnosis code which must be for somatic type pain</p>
<p>2) Prescriber attestation that the benefits and risks of opioid therapy has been discussed with patient</p></td>
<td>Y</td>
<td>0022</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>14</td>
<td>0022</td>
<td></td>
<td>Select</td>
<td>Does the provider attest that OARRS has been reviewed before initially prescribing or personally furnishing any controlled substance?</td>
<td>Y</td>
<td>0023</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>15</td>
<td>0023</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of the patient’s indication, previous utilization, and requested length of therapy?</td>
<td>Y </td>
<td>0024</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>16</td>
<td>0024</td>
<td></td>
<td>Select</td>
<td>Initial short-acting requests can be authorized up to 90 days. Does this request meet this requirement?</td>
<td>Y </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>17</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is the request for a dose escalation?</td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>18</td>
<td>1002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>Prescriber attestation that dose escalation is likely to result in improved function or pain control.</p></td>
<td>Y </td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>19</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td>Is the request for a cumulative daily dose greater than 80 MED?</td>
<td>Y </td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>20</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the medication being prescribed by or in consultation with a pain specialist, specialist in the area of the body affected by pain, or anesthesiologist?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y </td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>21</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Current treatment plan</p>
<p>2) Demonstrated adherence to treatment plan through progress notes, including pain and function scores, random urine screenings results reviewed, concerns addressed, and no serious adverse outcomes observed</p></td>
<td>Y </td>
<td>1006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>22</td>
<td>1006</td>
<td></td>
<td>Select</td>
<td>Subsequent short-acting and dose escalation requests can be authorized up to 180 days. Does this request meet this requirement?</td>
<td>Y</td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>23</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication, dose, and duration being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="even">
<td>24</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="odd">
<td>25</td>
<td>1237</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the dose and frequency being requested.</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: For the course of therapy, up to 180 days.
Initial short-acting and long-acting requests may only be authorized for
up to 90 days.

|||
| ------------------ | --------- |
| **Last Approved ** | 9/21/2023 |
| **Other**          |           |

## Preferred Products - Short Acting

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: Opioids</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Preferred Products- Short Acting</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>004163</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>004165</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>004169</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>045155</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>070212</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>070224</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUTALBITAL/ACETAMINOPHEN/CAFFEINE/CODEINE</td>
<td>004149</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUTALBITAL/ACETAMINOPHEN/CAFFEINE/CODEINE</td>
<td>071253</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUTALBITAL/ASPIRIN/CAFFEINE/CODEINE</td>
<td>004120</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUTORPHANOL</td>
<td>004287</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUTORPHANOL</td>
<td>004288</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUTORPHANOL</td>
<td>016674</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>CODEINE</td>
<td>004185</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>CODEINE</td>
<td>004186</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>CODEINE</td>
<td>004187</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>030623</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>047430</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>047431</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>053582</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>066836</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>068600</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>071384</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>071385</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROMORPHONE IR</td>
<td>004110</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROMORPHONE IR</td>
<td>004112</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROMORPHONE IR</td>
<td>015190</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROMORPHONE IR</td>
<td>016156</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROMORPHONE IR</td>
<td>004108</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>004087</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>004089</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>004090</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>004091</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>004092</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>071396</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NUCYNTA IR 50 MG TAB</td>
<td>065319</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>NUCYNTA IR 75 MG TAB</td>
<td>065320</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NUCYNTA IR 100 MG TAB</td>
<td>065321</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>004224</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>004225</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>013467</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>015065</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>024507</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>045298</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>046474</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>046475</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>069101</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>076361</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>078532</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>078533</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE/ACETAMINOPHEN</td>
<td>004221</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE/ACETAMINOPHEN</td>
<td>004222</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE/ACETAMINOPHEN</td>
<td>013998</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE/ACETAMINOPHEN</td>
<td>048976</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE/ACETAMINOPHEN</td>
<td>048977</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL</td>
<td>023139</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL</td>
<td>044978</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL/ACETAMINOPHEN</td>
<td>048456</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0009</td>
<td></td>
<td>Select and Free Text</td>
<td>Is the patient new to (initial request) or continuing therapy with the requested product (re-authorization request)?</td>
<td>Initial request for product </td>
<td>0010</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0010</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y</td>
<td>0011</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0011</td>
<td></td>
<td>Select</td>
<td><p>Does this request exceed 30 MED AND/OR exceed a 7 days supply (or 5 days supply if &lt;18 years old)?</p>
<p>Patients with initial prescriptions for opioid therapy, defined as no rx opioid claims in the last 90 days, will be limited to 30 MED per day and a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription.</p></td>
<td>Y</td>
<td>0012</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1237</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0012</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation to support the need for exceeding 30 MED per day and/or a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>0013</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0013</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient meet one of the following exemptions?</p>
<p>1) Diagnosis of active cancer treatment, palliative care, end-of-life/hospice care, sickle cell, severe burn, traumatic crushing of tissue, amputation, major orthopedic surgery </p>
<p>2) Prescriber attestation that patient is not opioid naïve (i.e., new to Medicaid or was on higher dose in hospital)</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0014</td>
</tr>
<tr class="odd">
<td>6</td>
<td>0014</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Diagnosis code which must be for somatic type pain</p>
<p>2) Prescriber attestation that the benefits and risks of opioid therapy has been discussed with patient</p></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>7</td>
<td>0015</td>
<td></td>
<td>Select</td>
<td>Does the provider attest that OARRS has been reviewed before initially prescribing or personally furnishing any controlled substance?</td>
<td>Y </td>
<td>0016</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>8</td>
<td>0016</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of the patient’s indication, previous utilization, and requested length of therapy?</td>
<td>Y</td>
<td>0017</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>9</td>
<td>0017</td>
<td></td>
<td>Select</td>
<td>Initial short-acting requests can be authorized up to 90 days. Does this request meet this requirement?</td>
<td>Y</td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>10</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is the request for a dose escalation?</td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>11</td>
<td>1002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>Prescriber attestation that dose escalation is likely to result in improved function or pain control.</p></td>
<td>Y </td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>12</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td>Is the request for a cumulative daily dose greater than 80 MED?</td>
<td>Y </td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>13</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the medication being prescribed by or in consultation with a pain specialist, specialist in the area of the body affected by pain, or anesthesiologist?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y </td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>14</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Current treatment plan</p>
<p>2) Demonstrated adherence to treatment plan through progress notes, including pain and function scores, random urine screenings results reviewed, concerns addressed, and no serious adverse outcomes observed</p></td>
<td>Y</td>
<td>1006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>15</td>
<td>1006</td>
<td></td>
<td>Select</td>
<td>Subsequent short-acting and dose escalation requests can be authorized up to 180 days. Does this request meet this requirement?</td>
<td>Y</td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>16</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication, dose, and duration being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="even">
<td>17</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="odd">
<td>18</td>
<td>1237</td>
<td></td>
<td>Free Text</td>
<td>Prior Authorization for a preferred short-acting opioid is only required if the initial request (defined as no opioids in the previous 90 days) exceeds 30 MED AND/OR exceeds a 7 days supply (or 5 days supply if &lt;18 years old).</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: For the course of therapy, up to 180 days.
Initial short-acting and long-acting requests may only be authorized for
up to 90 days.

|||
| ------------------ | --------- |
| **Last Approved ** | 9/21/2023 |
| **Other**          |           |
